AR and cancer: We further documented that during transformation of androgen-responsive normal prostatic epithelial to malignant cancer cells, a shift in the AR axis from a stromal cell-dependent paracrine pathway to a cancer cell autonomous autocrine-dependent pathways occurs such that now ligand-dependent AR signaling is oncogenic, driving both malignant cell survival as well as proliferation [16,17,18].